What Are Neurobiome-Directed Interventions (NDIs)? The Next Chapter After “Psychobiotics”
Quick answer: Psychobiotics is the research term for gut bacteria studied for their effects on mood, stress and cognition through the gut-brain axis. Neurobiome-directed interventions (NDIs) take that science further than a probiotic: a gut-brain formula aimed at your neurobiome — the gut-brain portion of your microbiome — and matched to how your gut-brain axis actually behaves. It starts in the gut. Same biology, sharper targeting.
In 2013, researchers Ted Dinan and John Cryan introduced a word for a strange, exciting idea: that certain gut bacteria could act on the brain. They called them psychobiotics — “a novel class of psychotropic.” The name stuck in the literature, and a decade of studies followed the thread from the gut to mood, stress and sleep.
At GoodOnes we build on that science, but what we make isn’t just a probiotic. We call it a neurobiome-directed intervention, or NDI. The shift from psychobiotics to NDIs — and from the psychobiome to the neurobiome — isn’t marketing. It reflects what modern gut-brain work is actually about: not vague “psych” effects, but specific neuro-active pathways in a specific, measurable part of your microbiome.
From psychobiotics to NDIs: why the framing changed
The original term, psychobiotics, framed the field around psychology — mood and behavior. That was the right starting point. But as the science matured, the interesting action turned out to be neurological and biochemical: bacteria that produce or regulate neurotransmitter precursors, short-chain fatty acids that signal along the vagus nerve, and metabolites that touch the gut’s own dense network of neurons.
An NDI names that target directly. It’s a formula chosen for the gut-brain axis — the neurobiome — rather than a general “good bacteria” blend. It’s the difference between “this may help your mood” and “this was selected for the pathway your pattern is missing.”
What is the neurobiome?
Your neurobiome is the slice of your gut microbiome that talks to your brain. The conversation runs on three well-studied channels: the vagus nerve (a direct gut-to-brain line), neurotransmitter precursors (gut microbes influence the raw materials for serotonin, GABA and dopamine), and short-chain fatty acids like butyrate that shape the gut lining and immune signalling.
The enteric nervous system — the gut’s own “second brain” — contains hundreds of millions of neurons. That’s why the gut-brain axis is real biology, not a metaphor, and why the makeup of your neurobiome has been studied in relation to stress reactivity, sleep and focus.
How NDIs are studied to work
Across the psychobiotics literature, specific strains have been studied for effects on stress hormones, GABA signaling and serotonin pathways in preclinical and early clinical work. The effects are strain-specific and, importantly, person-specific — which is the whole point of targeting.
That’s why a GoodOnes NDI is more than a probiotic. Each one pairs a gut-brain probiotic base with prebiotic fibers and a focused neuro-active layer — ingredients like GABA, 5-HTP, Lion’s Mane, Reishi and Melatonin — chosen to match a specific neurobiome pattern. This is structure/function support for everyday gut-brain balance; it is not a drug and is not intended to diagnose or treat any condition.
The six neurobiome patterns
People don’t share one gut-brain profile, so one “mood probiotic” can’t fit everyone. GoodOnes maps six neurobiome patterns — from the wired, low-GABA pattern to the slow-gut, flat-mood serotonin pattern — each with a matched Neurobiome Intervention formula: Ease, Flow, Cool, Settle, Rebuild and Steady.
You don’t guess which one you are. Assess first, then match: the assessment reads how your gut-brain axis behaves and points you to the formula.
For the wired, low-GABA pattern
Ease — GABA-pattern calm & stress support
References
- Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012;13(10):701–712.
- Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biol Psychiatry. 2013;74(10):720–726.
- Sarkar A, Lehto SM, Harty S, et al. Psychobiotics and the manipulation of bacteria–gut–brain signals. Trends Neurosci. 2016;39(11):763–781.
- Cryan JF, O’Riordan KJ, Cowan CSM, et al. The microbiota–gut–brain axis. Physiol Rev. 2019;99(4):1877–2013.
This article is for education and does not diagnose, treat, cure, or prevent any disease. GoodOnes™ formulations support everyday gut function; they are not a substitute for medical care. If your symptoms are severe, persistent, or accompanied by warning signs, see a licensed clinician.
About the author
Craig Rouskey · CEO, Flore Inc. & Microbiome Scientist
MSc Molecular Biology, Microbiology, Biochemistry & Immunology (SIU). Craig is the scientist behind the GoodOnes™ targeted-probiotic line, built on a longitudinal dataset of 23,447 sequenced microbiomes. Former leadership at Renegade Bio, Pando Nutrition, and Bionascent; TEDxBellevue speaker on citizen science and precision health.